UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $157,320 | -54.7% | 15,200 | -59.6% | 0.00% | -100.0% |
| Q1 2023 | $347,424 | -23.5% | 37,600 | -26.6% | 0.00% | 0.0% |
| Q4 2022 | $454,144 | -8.4% | 51,200 | -14.1% | 0.00% | -50.0% |
| Q3 2022 | $496,000 | -19.0% | 59,600 | -20.2% | 0.00% | 0.0% |
| Q2 2022 | $612,000 | +74.9% | 74,700 | +85.9% | 0.00% | +100.0% |
| Q1 2022 | $350,000 | -41.0% | 40,192 | +32.1% | 0.00% | 0.0% |
| Q1 2021 | $593,000 | +11.3% | 30,427 | +2.9% | 0.00% | 0.0% |
| Q4 2020 | $533,000 | -20.2% | 29,569 | -14.6% | 0.00% | -50.0% |
| Q3 2020 | $668,000 | -20.9% | 34,644 | +7.2% | 0.00% | 0.0% |
| Q2 2020 | $844,000 | +55.4% | 32,324 | +6.2% | 0.00% | 0.0% |
| Q1 2020 | $543,000 | -42.1% | 30,423 | +8.3% | 0.00% | 0.0% |
| Q4 2019 | $938,000 | +40.0% | 28,100 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $670,000 | – | 28,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Horton Capital Management, LLC | 684,749 | $11,517,000 | 23.27% |
| GREAT POINT PARTNERS LLC | 750,000 | $12,615,000 | 2.94% |
| HealthInvest Partners AB | 75,000 | $1,262,000 | 1.89% |
| Wildcat Capital Management, LLC | 533,139 | $8,967,000 | 1.16% |
| Annandale Capital, LLC | 86,254 | $1,451,000 | 0.87% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $49,698,000 | 0.73% |
| ZEKE CAPITAL ADVISORS, LLC | 723,677 | $12,172,000 | 0.70% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $426,000 | 0.34% |
| RTW INVESTMENTS, LP | 857,464 | $14,423,000 | 0.22% |
| SHIKIAR ASSET MANAGEMENT INC | 33,350 | $561,000 | 0.16% |